Cigna Group shares rise as Q2 results top estimates

Published 31/07/2025, 11:38
© Reuters

Investing.com -- The Cigna (NYSE:CI) Group reported better-than-expected second quarter 2025 results on Wednesday, as strong growth in its Evernorth Health Services segment drove revenue significantly higher. Shares rose 1% following the announcement.

The health services company posted adjusted earnings of $7.20 per share, exceeding analyst expectations of $7.16. Revenue surged 11% YoY to $67.2 billion, well above the consensus estimate of $62.66 billion. The company reaffirmed its full-year 2025 adjusted earnings outlook of at least $29.60 per share, slightly below analyst projections of $29.69.

Evernorth Health Services, which includes pharmacy benefit management and specialty pharmacy services, was the primary growth driver with adjusted revenues increasing 17% to $57.8 billion compared to the same period last year. The segment’s pre-tax adjusted income rose 5% to $1.7 billion.

"Listening, adapting, and innovating to meet the evolving needs of our patients, customers, and clients enables us to deliver meaningful value," said David M. Cordani, chairman and CEO of The Cigna Group. "Our performance in the second quarter reflects our disciplined execution and the strength of our business mix."

The Cigna Healthcare segment saw adjusted revenues decrease 18% to $10.8 billion, primarily due to the divestiture of its Medicare businesses to Health Care Services Corporation in March 2025. Excluding this transaction, the segment’s revenue would have increased 7% YoY.

The company’s medical care ratio rose to 83.2% from 82.3% in the year-ago quarter, reflecting expected higher stop loss medical costs.

Total (EPA:TTEF) pharmacy customers increased 3% from December 31, 2024, to 121.9 million, while total medical customers decreased 6% to 18 million, primarily due to the HCSC transaction.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.